European Journal of Therapeutics is a distinguished journal dedicated to advancing the field of therapeutic sciences through high-quality research and innovative clinical practice. Published by Pera Yayincilik Hizmetleri, this interdisciplinary journal aims to facilitate knowledge dissemination in areas such as pharmacology, clinical medicine, and public health, thereby supporting both researchers and practitioners in improving therapeutic outcomes. Although the journal operates under a subscription model, its commitment to rigorous peer review ensures that published articles reflect the latest advancements and methodologies. With a growing emphasis on evidence-based therapies, the European Journal of Therapeutics serves as a vital platform for dialogue among healthcare professionals and researchers, enhancing the understanding of therapeutic interventions on a global scale. It welcomes contributions ranging from original research to review articles, making it an essential resource for those seeking to enrich their knowledge and influence practice in therapeutic approaches.

REVISTA MEDICA DE CHILE is a distinguished medical journal published by the SOCIEDAD MEDICA SANTIAGO, dedicated to advancing the field of medicine in Chile and beyond. Since its inception in 1945, this journal has served as a vital platform for the dissemination of high-quality research and clinical studies, addressing a wide spectrum of topics within the field of medicine. Currently indexed in Scopus with a rank of 314 out of 636 in the General Medicine category, the journal holds a Q4 categorization and represents the median percentile range, indicating its emerging influence within the scholarly community. Although REVISTA MEDICA DE CHILE does not offer Open Access, it remains accessible to a broad readership keen on exploring recent findings and advancements. Scholars, practitioners, and students will find value in the journal's commitment to fostering knowledge exchange and encouraging innovation in healthcare, making it an essential resource for anyone invested in the medical sciences.

American Journal of Medicine, published by Elsevier Science Inc, stands as a leading platform in the field of medicine, dedicated to advancing our understanding of general medical practices since its inception in 1946. With a reputable impact factor and categorized in the prestigious Q1 quartile for medicine (miscellaneous) in 2023, this journal ranks impressively at #66 out of 636 in its category on Scopus, placing it in the 89th percentile. The journal publishes peer-reviewed articles that span a broad spectrum of medical disciplines, offering invaluable insights and current research findings for healthcare professionals, researchers, and students alike. Although it does not provide open access, the journal's commitment to quality and innovation in clinical practice continues to influence medical professionals globally.

SAGE Open Medicine, published by SAGE Publications Inc, stands as an influential open-access journal in the realm of medicine since its inception in 2013. With an ISSN of 2050-3121, this journal facilitates a dynamic platform for the dissemination of rigorous research across a variety of medical disciplines, encompassing extensive topics that range from clinical practice to healthcare policy. Based in the United Kingdom, SAGE Open Medicine has quickly ascended in prominence, achieving a Q2 ranking in the Medicine (miscellaneous) category and securing an impressive placement as #149 out of 636 in the Scopus rankings for general medicine, which places it in the 76th percentile. The journal's commitment to accessibility ensures that researchers, practitioners, and students alike can readily engage with cutting-edge health research that shapes contemporary medical practice. By offering a rigorous peer-review process alongside expedited publication timelines, SAGE Open Medicine remains dedicated to fostering scholarly dialogue and advancing the field of medicine.

Welcome to the JCPSP-Journal of the College of Physicians and Surgeons Pakistan, a pivotal platform for advancing knowledge in the field of medicine. Published by the College of Physicians and Surgeons Pakistan, this distinguished journal, with the ISSN 1022-386X and E-ISSN 1681-7168, has been disseminating critical research and clinical insights since 1996. With a focus on various realms of general medicine and holding a current Scopus rank of #291 out of 636, the JCPSP is classified in the Q3 quartile for miscellaneous medicine, indicating its growing influence and expertise. The journal aims to foster scholarly communication and collaboration among healthcare professionals, researchers, and students in Pakistan and beyond, enhancing clinical practice and medical education. Although it does not currently offer Open Access, its curated content and comprehensive research articles are essential for those engaged in the medical sciences. Join us in exploring the latest findings and contributions impacting the healthcare landscape in Pakistan and worldwide.

Bahrain Medical Bulletin is a vital platform in the field of medical research, dedicated to enhancing the knowledge base and practice of healthcare in Bahrain and beyond. Published by the BAHRAIN MEDICAL BULLETIN, this journal has consistently provided valuable insights since its inception in 1990 and continues to be a significant contributor to the medical literature up to 2024. Although classified in the Q4 quartile in the category of Medicine (miscellaneous) and holding a Scopus rank of 435 out of 636, the journal aims to promote a wide array of medical and health-related disciplines, making it an essential resource for researchers, professionals, and students alike. While currently not an open-access journal, it strives to facilitate the dissemination of relevant studies and clinical findings that address regional and global health challenges. The Bahrain Medical Bulletin serves as a critical hub for fostering collaboration and innovation in medical research within the Kingdom of Bahrain and the surrounding regions.

Marmara Medical Journal, published by Marmara University, Faculty of Medicine, is a peer-reviewed academic journal that has been a significant platform for the dissemination of medical research since its inception in 1996. With an ISSN of 1309-9469, this journal operates from Turkey and serves the global medical community with a commitment to advancing medical knowledge and practice. Although currently classified in the Q4 category in the field of Medicine (Miscellaneous) and ranked at the 18th percentile in Scopus, Marmara Medical Journal embraces a broad scope by including diverse topics within the medical sciences, which fosters interdisciplinary research. Researchers and practitioners are encouraged to contribute by submitting their findings, fostering a dynamic exchange of knowledge. Our mission is to support both new and established medical professionals in addressing contemporary healthcare challenges through rigorous research, thus enhancing the impact of medical literature in Turkey and beyond.

Revista da Associacao Medica Brasileira, with ISSN 0104-4230 and E-ISSN 1806-9282, is a premier open access journal published by the Associacao Medica Brasileira, located in São Paulo, Brazil. Established in 1976, it has transitioned to an open access model since 1997, making significant contributions to the field of medicine by ensuring that research is freely accessible to a global audience. The journal covers a broad spectrum of medical topics, catering to the diverse interests of researchers, healthcare professionals, and students, and holds a commendable position in the Scopus rankings, being placed in the 63rd percentile of general medicine journals, ranked #230 out of 636. With its commitment to disseminating valuable medical knowledge, Revista da Associacao Medica Brasileira has solidified its role as a vital resource for advancing medical research and practice in Brazil and beyond.

ANNALS ACADEMY OF MEDICINE SINGAPORE is a reputable journal dedicated to the field of medicine, published by the Academy of Medicine, Singapore. With an E-ISSN of 2972-4066, this journal has been an influential platform since its inception in 1973, aiming to disseminate high-quality research and clinical findings pertinent to both local and international audiences. Currently ranked in the Q3 quartile in Medicine (miscellaneous), it holds a commendable 83rd percentile in Scopus rankings, indicating its significant academic contribution within the competitive landscape of medical literature. Although the journal operates on a traditional subscription-based model, it continues to provide access to critical insights that serve not only researchers but also healthcare professionals and students engaged in the ever-evolving medical sector. As it approaches its comprehensive publication mark in 2024, ANNALS will continue to focus on enhancing global healthcare discourse, making it an invaluable resource for those committed to advancing medical knowledge and practice.

Revista del Cuerpo Medico del Hospital Nacional Almanzor Aguinaga Asenjo is a prominent medical journal published by the renowned Hospital Nacional Almanzor Aguinaga Asenjo in Peru. With the ISSN 2225-5109 and E-ISSN 2227-4731, this open-access journal has been serving the medical community since its inception in 2019. It aims to disseminate vital research and insights in the fields of health and medicine, providing a platform for the exchange of knowledge on critical issues affecting public health and healthcare policy in Latin America. Although classified in the Q4 category for both Health (social science) and Medicine (miscellaneous) in 2023, its essential contributions to health professions and policy add significant value to researchers and practitioners alike. Positioned within the context of a rapidly evolving healthcare landscape, the journal is crucial for fostering a better understanding of the challenges and innovations in healthcare delivery and medical practice. Researchers, professionals, and students looking to deepen their understanding of these fields will find this journal invaluable as it continues to grow and adapt through 2024 and beyond.